Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Earlier somatomedin-1 use linked with greater benefit in ALS

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Earlier somatomedin-1 use linked with greater benefit in ALS. Pharmacoecon. Outcomes News 205, 8 (1999). https://doi.org/10.1007/BF03295078

    Download citation

    Keywords

    • Placebo
    • Amyotrophic Lateral Sclerosis
    • Cost Effectiveness
    • Rapid Progressors
    • Compliance Rate